Rhodiola sacra is a widely used pharmaceutical component with multiple functions, including anti-oxidation and anti-inflammation. However, the exact mechanisms involved in neuroprotection against transient global cerebral ischemia (tGCI) remain to be elucidated. Herein, we aim at closing the gap in understanding on whether rhodiola sacra reduces neuronal death in hippocampal CA1 and at demonstrating how rhodiola sacra offers neuroprotection after tGCI.
Results:
The results show that rhodiola sacra (2.4 g/kg/d by feeding) pretreatment or/and postreatment significantly alleviated neuronal injury, inhibited glial activation, and improved cognitive function in male rats subjected to tGCI. The neuroprotection of prophylaxis with rhodiola sacra is equivalent to that of therapeutics. The binding mode of adenosine monophosphate-activated protein kinase (AMPK) α2-subunit with rhodiola sacra was predicted by molecular docking. Further, rhodiola sacra upregulates phosphorylated AMPK and promotes nuclear translocation of nuclear factor erythroid 2 related factor 2 (Nrf2). In addition, rhodiola sacra increases heme oxygenase-1 (HO-1) expression and activity and reduces malondialdehyde (MDA) content in CA1 after tGCI. However, the neuroprotection of rhodiola sacra is abolished by Nrf2 knockdown with small interfering RNA (siRNA) after tGCI. Similarly, the inhibition of AMPK with Compound C or siRNA against AMPK α2 aggravates neuronal death after tGCI through decreasing nuclear Nrf2 and the expression and activity of HO-1, and by increasing the release of MDA.
Innovation and Conclusion:
For the first time, this study demonstrates that as a prophylactic or therapeutic agent rhodiola sacra prevents oxidant stress, protects neurons, and improves cognitive function through activating the AMPK/Nrf2 pathway in tGCI rats. Antioxid. Redox Signal. 36, 567–591.
Get full access to this article
View all access options for this article.
References
1.
AllenCL, and BayraktutanU. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke, 4: 461–470, 2009.
2.
AshabiG, KhalajL, KhodagholiF, GoudarzvandM, and SarkakiA. Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab Brain Dis, 30: 747–754, 2015.
3.
AtochinDN, ChernyshevaGA, SmolyakovaVI, OsipenkoAN, LogvinovSV, ZhdankinaAA, SysolyatinSV, KryukovYA, AnfinogenovaY, PlotnikovaTM, and PlotnikovMB. Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats. Phytomedicine, 23: 784–792, 2016.
4.
BasuM, SahaS, and UkilA. Spectrophotometric Assessment of Heme Oxygenase-1 Activity in Leishmania-infected Macrophages. Bio Protoc, 10: e3578, 2020.
5.
BrunettiG, Di RosaG, ScutoM, LeriM, StefaniM, Schmitz-LinneweberC, CalabreseV, and SaulN. Healthspan Maintenance and Prevention of Parkinson's-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans. Int J Mol Sci, 21: 2588, 2020.
6.
CalabreseEJ, CalabreseV, TsatsakisA, and GiordanoJJ. Hormesis and Ginkgo biloba (GB): numerous biological effects of GB are mediated via hormesis. Ageing Res Rev, 64: 101019, 2020.
7.
CalabreseV, CorneliusC, Dinkova-KostovaAT, CalabreseEJ, and MattsonMP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal, 13: 1763–1811, 2010.
8.
CalabreseV, SantoroA, MontiD, CrupiR, Di PaolaR, LatteriS, CuzzocreaS, ZappiaM, GiordanoJ, CalabreseEJ, and FranceschiC. Aging and Parkinson's Disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med, 115: 80–91, 2018.
9.
CampbellB, MaH, RinglebPA, ParsonsMW, ChurilovL, BendszusM, LeviCR, HsuC, KleinigTJ, FatarM, LeysD, MolinaC, WijeratneT, CurtzeS, DeweyHM, BarberPA, ButcherKS, De SilvaDA, BladinCF, YassiN, PfaffJ, SharmaG, BivardA, DesmondPM, SchwabS, SchellingerPD, YanB, MitchellPJ, SerenaJ, ToniD, ThijsV, HackeW, DavisSM, and DonnanGA. Extending thrombolysis to 4.5–9h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet, 394: 139–147, 2019.
10.
ChenB, LuY, ChenY, and ChengJ. The role of Nrf2 in oxidative stress-induced endothelial injuries. J Endocrinol, 225: R83–R99, 2015.
11.
ChenC, HouC, BernardJR, ChenC, HungT, ChengL, LiaoY, and KuoC. Rhodiola crenulata-andCordyceps sinensis-Based Supplement Boosts Aerobic Exercise Performance after Short-Term High Altitude Training. High Alt Med Biol, 15: 371–379, 2014.
12.
CropleyM, BanksAP, and BoyleJ. The effects of rhodiola rosea L. Extract on anxiety, stress, cognition and other mood symptoms. Phytother Res, 29: 1934–1939, 2015.
13.
DamodaranT, HassanZ, NavaratnamV, MuzaimiM, NgG, MüllerCP, LiaoP, and DringenbergHC. Time course of motor and cognitive functions after chronic cerebral ischemia in rats. Behav Brain Res, 275: 252–258, 2014.
14.
DasguptaB and SeibelW. Compound C/Dorsomorphin: its use and misuse as an AMPK inhibitor. Methods Mol Biol, 1732: 195–202, 2018.
15.
DuanJ, CuiJ, YangZ, GuoC, CaoJ, XiM, WengY, YinY, WangY, WeiG, QiaoB, and WenA. Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3beta/Nrf2 signaling. J Neuroinflammation, 16: 24, 2019.
16.
EijkelenboomA and BurgeringBM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol, 14: 83–97, 2013.
17.
GondardE, TevesL, WangL, McKinnonC, HamaniC, KaliaSK, CarlenPL, TymianskiM, and LozanoAM. Deep Brain Stimulation Rescues Memory and Synaptic Activity in a Rat Model of Global Ischemia. J Neurosci, 39: 2430–2440, 2019.
18.
GuoN, ZhuM, HanX, SuiD, WangY, and YangQ. The metabolism of salidroside to its aglycone p-tyrosol in rats following the administration of salidroside. PLoS One, 9: e103648, 2014.
19.
HanJ, XiaoQ, LinYH, ZhengZZ, HeZD, HuJ, and ChenLD. Neuroprotective effects of salidroside on focal cerebral ischemia/reperfusion injury involve the nuclear erythroid 2-related factor 2 pathway. Neural Regen Res, 10: 1989–1996, 2015.
20.
HawleySA, DavisonM, WoodsA, DaviesSP, BeriRK, CarlingD, and HardieDG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem, 271: 27879–27887, 1996.
21.
HuangW, CaoJ, LiuX, MengF, LiM, ChenB, and ZhangJ. AMPK plays a dual role in regulation of CREB/BDNF pathway in mouse primary hippocampal cells. J Mol Neurosci, 56: 782–788, 2015.
22.
HunsakerMR and KesnerRP. Unfolding the cognitive map: the role of hippocampal and extra-hippocampal substrates based on a systems analysis of spatial processing. Neurobiol Learn Mem, 147: 90–119, 2018.
23.
JägerS, HandschinC, St-PierreJ, and SpiegelmanBM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A, 104: 12017–12022, 2007.
24.
JiLL and YeoD. Mitochondrial dysregulation and muscle disuse atrophy. F1000Res 8: F1000 Faculty Re, v-1621, 2019.
25.
JiangS, LiT, JiT, YiW, YangZ, WangS, YangY, and GuC. AMPK: potential therapeutic target for ischemic stroke. Theranostics, 8: 4535–4551, 2018.
26.
JiangT, YuJT, ZhuXC, WangHF, TanMS, CaoL, ZhangQQ, GaoL, ShiJQ, ZhangYD, and TanL. Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy. Br J Pharmacol, 171: 3146–3157, 2014.
27.
JooMS, KimWD, LeeKY, KimJH, KooJH, and KimSG. AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550. Mol Cell Biol, 36: 1931–1942, 2016.
28.
LeeJ and KimS. Upregulation of heme oxygenase-1 expression by dehydrodiconiferyl alcohol (DHCA) through the AMPK-Nrf2 dependent pathway. Toxicol Appl Pharmacol, 281: 87–100, 2014.
29.
LiJ, BenashskiSE, VennaVR, and McCulloughLD. Effects of metformin in experimental stroke. Stroke, 41: 2645–2652, 2010.
30.
LiJ, ZengZ, ViolletB, RonnettGV, and McCulloughLD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke, 38: 2992–2999, 2007.
31.
LiL, ZhangX, CuiL, WangL, LiuH, JiH, and DuY. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res, 1497: 32–39, 2013.
32.
LinS and HardieDG. AMPK: sensing glucose as well as cellular energy status. Cell Metab, 27: 299–313, 2018.
33.
LiuX, ChhipaRR, NakanoI, and DasguptaB. The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent. Mol Cancer Ther, 13: 596–605, 2014.
34.
LiuX, WenS, YanF, LiuK, LiuL, WangL, ZhaoS, and JiX. Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia. J Neuroinflamm 15: 2018.
35.
MaG, ZhengQ, XuM, ZhouX, LuL, LiZ, and ZhengG. Rhodiola rosea L. Improves learning and memory function: preclinical evidence and possible mechanisms. Front Pharmacol, 9: 1415, 2018.
36.
MaH, CampbellB, ParsonsMW, ChurilovL, LeviCR, HsuC, KleinigTJ, WijeratneT, CurtzeS, DeweyHM, MiteffF, TsaiCH, LeeJT, PhanTG, MahantN, SunMC, KrauseM, SturmJ, GrimleyR, ChenCH, HuCJ, WongAA, FieldD, SunY, BarberPA, SabetA, JannesJ, JengJS, ClissoldB, MarkusR, LinCH, LienLM, BladinCF, ChristensenS, YassiN, SharmaG, BivardA, DesmondPM, YanB, MitchellPJ, ThijsV, CareyL, MeretojaA, DavisSM, and DonnanGA. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med, 380: 1795–1803, 2019.
37.
MaoGX, DengHB, YuanLG, LiDD, LiYY, and WangZ. Protective role of salidroside against aging in a mouse model induced by D-galactose. Biomed Environ Sci, 23: 161–166, 2010.
38.
MiaoZY, XiaX, CheL, and SongYT. Genistein attenuates brain damage induced by transient cerebral ischemia through up-regulation of Nrf2 expression in ovariectomized rats. Neurol Res, 40: 689–695, 2018.
39.
MiquelS, ChampC, DayJ, AartsE, BahrBA, BakkerM, BánátiD, CalabreseV, CederholmT, CryanJ, DyeL, FarrimondJA, KorosiA, LayéS, MaudsleyS, MilenkovicD, MohajeriMH, SijbenJ, SolomonA, SpencerJ, ThuretS, VandenBW, VauzourD, VellasB, WesnesK, WillattsP, WittenbergR, and GeurtsL. Poor cognitive ageing: vulnerabilities, mechanisms and the impact of nutritional interventions. Ageing Res Rev, 42: 40–55, 2018.
40.
MorettiA, FerrariF, and VillaRF. Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol Ther, 146: 23–34, 2015.
41.
MotohashiH and YamamotoM. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med, 10: 549–557, 2004.
42.
NogueiraRG, JadhavAP, HaussenDC, BonafeA, BudzikRF, BhuvaP, YavagalDR, RiboM, CognardC, HanelRA, SilaCA, HassanAE, MillanM, LevyEI, MitchellP, ChenM, EnglishJD, ShahQA, SilverFL, PereiraVM, MehtaBP, BaxterBW, AbrahamMG, CardonaP, VeznedarogluE, HellingerFR, FengL, KirmaniJF, LopesDK, JankowitzBT, FrankelMR, CostalatV, VoraNA, YooAJ, MalikAM, FurlanAJ, RubieraM, AghaebrahimA, OlivotJM, TekleWG, ShieldsR, GravesT, LewisRJ, SmithWS, LiebeskindDS, SaverJL, and JovinTG. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med, 378: 11–21, 2018.
43.
OnkenB and DriscollM. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One, 5: e8758, 2010.
44.
PanossianA, WikmanG, and SarrisJ. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine, 17: 481–493, 2010.
45.
PulsinelliWA, BrierleyJB, and PlumF. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol, 11: 491–498, 1982.
46.
PulsinelliWA and BrierleyJB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke, 10: 267–272, 1979.
47.
RyterSW, KvamE, and TyrrellRM. Heme oxygenase activity. Current methods and applications. Methods Mol Biol, 99: 369–391, 2000.
48.
ShahZA, LiRC, ThimmulappaRK, KenslerTW, YamamotoM, BiswalS, and DoreS. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience, 147: 53–59, 2007.
49.
ShanskyRM and MurphyAZ. Considering sex as a biological variable will require a global shift in science culture. Nat Neurosci, 24: 457–464, 2021.
50.
ShiT, FengS, XingJ, WuY, LiX, ZhangN, TianZ, LiuS, and ZhaoM. Neuroprotective Effects of Salidroside and its Analogue Tyrosol Galactoside Against Focal Cerebral Ischemia In Vivo and H2O2-Induced Neurotoxicity In Vitro. Neurotox Res, 21: 358–367, 2012.
51.
SiracusaR, ScutoM, FuscoR, TrovatoA, OntarioML, CreaR, Di PaolaR, CuzzocreaS, and CalabreseV. Anti-inflammatory and Anti-oxidant Activity of Hidrox® in Rotenone-Induced Parkinson's Disease in Mice. Antioxidants (Basel), 9: 824, 2020.
52.
SpasićMR, CallaertsP, and NorgaKK. AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons. Neuroscientist, 15: 309–316, 2009.
53.
TsikasD.Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal Biochem, 524: 13–30, 2017.
54.
TurnleyAM, StapletonD, MannRJ, WittersLA, KempBE, and BartlettPF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem, 72: 1707–1716, 1999.
55.
WangB, ZhuX, KimY, LiJ, HuangS, SaleemS, LiR, XuY, DoreS, and CaoW. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radical Bio Med, 52: 928–936, 2012.
56.
WangJM, QuZQ, WuJL, ChungP, and ZengYS. Mitochondrial protective and anti-apoptotic effects of Rhodiola crenulata extract on hippocampal neurons in a rat model of Alzheimer's disease. Neural Regen Res, 12: 2025–2034, 2017.
57.
WangY, ZhanL, ZengW, LiK, SunW, XuZC, and XuE. Downregulation of Hippocampal GABA after Hypoxia-Induced Seizures in Neonatal Rats. Neurochem Res, 36: 2409–2416, 2011.
58.
WeiY, HongH, ZhangX, LaiW, WangY, ChuK, BrownJ, HongG, and ChenL. Salidroside Inhibits Inflammation Through PI3K/Akt/HIF signaling after focal cerebral ischemia in rats. Inflammation, 40: 1297–1309, 2017.
59.
WenH, LiuL, ZhanL, LiangD, LiL, LiuD, SunW, and XuE. Neuroglobin mediates neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na(+)/K(+) ATPases. Cell Death Dis, 9: 635, 2018.
60.
WonSJ, KimJE, Cittolin-SantosGF, and SwansonRA. Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress. J Neurosci, 35: 7143–7152, 2015.
61.
WuW, WangS, LiuQ, WangX, ShanT, and WangY. Cathelicidin-WA attenuates LPS-induced inflammation and redox imbalance through activation of AMPK signaling. Free Radic Biol Med, 129: 338–353, 2018.
62.
XiaoL, LiH, ZhangJ, YangF, HuangA, DengJ, LiangM, MaF, HuM, and HuangZ. Salidroside protects caenorhabditis elegans neurons from polyglutamine-mediated toxicity by reducing oxidative stress. Molecules, 19: 7757–7769, 2014.
63.
YellonDM and HausenloyDJ. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med, 2: 568–575, 2005.
64.
YuS, LiuL, WenT, LiuY, WangD, HeY, LiangY, LiuX, XieL, WangG, and WeiW. Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the determination of salidroside in rat plasma: application to the pharmacokinetics study. J Chromatogr B Analyt Technol Biomed Life Sci, 861: 10–15, 2008.
65.
YuS, XuH, ChiX, WeiL, ChengQ, YangY, ZhouC, and DingF. 2-(4-Methoxyphenyl)ethyl-2-Acetamido-2-deoxy-beta-d-pyranoside (A Salidroside Analog) Confers Neuroprotection with a Wide Therapeutic Window by Regulating Local Glucose Metabolism in a Rat Model of Cerebral Ischemic Injury. Neuroscience, 391: 60–72, 2018.
66.
ZhanL, LiD, LiangD, WuB, ZhuP, WangY, SunW, and XuE. Activation of Akt/FoxO and inactivation of MEK/ERK pathways contribute to induction of neuroprotection against transient global cerebral ischemia by delayed hypoxic postconditioning in adult rats. Neuropharmacology, 63: 873–882, 2012.
67.
ZhanL, WangT, LiW, XuZC, SunW, and XuE. Activation of Akt/FoxO signaling pathway contributes to induction of neuroprotection against transient global cerebral ischemia by hypoxic pre-conditioning in adult rats. J Neurochem, 114: 897–908, 2010.
68.
ZhangB, WeiK, LiX, HuR, QiuJ, ZhangY, YaoW, ZhangC, and ZhuC. Upregulation of Cdh1 signaling in the hippocampus attenuates brain damage after transient global cerebral ischemia in rats. Neurochem Int, 112: 166–178, 2018.
69.
ZhangJ, XiaoF, ZhangL, WangX, LaiX, ShenY, ZhangM, ZhouB, LangH, YuP, and HuaF.Alpha-Lipoic Acid Preconditioning and Ischaemic Postconditioning Synergistically Protect Rats from Cerebral Injury Induced by Ischemia and Reperfusion Partly via Inhibition TLR4/MyD88/NF-κB Signaling Pathway. Cell Physiol Biochem, 51: 1448–1460.
70.
ZhangJ, ZhenYF, Pu-Bu-Ci-Ren, SongLG, KongWN, ShaoTM, LiX, and ChaiXQ. Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus. Behav Brain Res, 244: 70–81, 2013.
71.
ZhangR, XuM, WangY, XieF, ZhangG, and QinX. Nrf2-a promising therapeutic target for defensing against oxidative stress in stroke. Mol Neurobiol, 54: 6006–6017, 2017.
72.
ZhangX, LaiW, YingX, XuL, ChuK, BrownJ, ChenL, and HongG. Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFκB Signaling Rather than Complement C3 Activity. Inflammation, 42: 1830–1842, 2019.
73.
ZhangY, LiL, LinL, LiuJ, ZhangZ, XuD, and XiangF. Pharmacokinetics, tissue distribution, and excretion of salidroside in rats. Planta Med, 79: 1429–1433, 2013.
74.
ZhouF, WangM, JuJ, WangY, LiuZ, ZhaoX, YanY, YanS, LuoX, and FangY. Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. Am J Transl Res, 11: 199–209, 2019.
75.
ZhouM, WangH, ZengX, YinP, ZhuJ, ChenW, LiX, WangL, WangL, LiuY, LiuJ, ZhangM, QiJ, YuS, AfshinA, GakidouE, GlennS, KrishVS, Miller-PetrieMK, Mountjoy-VenningWC, MullanyEC, RedfordSB, LiuH, NaghaviM, HaySI, WangL, MurrayCJL, and LiangX. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 394: 1145–1158, 2019.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
